Neurobiology of the early course of schizophrenia

References

• Green MF, Kern RS, Heaton RK. Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr. Res.72(1), 41–51 (2004).
   PubMed Web of Science ®Google Scholar
• Keefe RS, Fenton WS. How should DSM-V criteria for schizophrenia include cognitive impairment? Schizophr. Bull.33(4), 912–920 (2007).
   PubMed Web of Science ®Google Scholar
• Brekke JS, Hoe M, Long J, Green MF. How neurocognition and social cognition influence functional change during community-based psychosocial rehabilitation for individuals with schizophrenia. Schizophr. Bull.33(5), 1247–1256 (2007).
   PubMed Web of Science ®Google Scholar
• Klosterkotter J, Hellmich M, Steinmeyer EM, Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch. Gen. Psychiatry58(2), 158–164 (2001).
   PubMed Web of Science ®Google Scholar
• Lencz T, Smith CW, McLaughlin D et al. Generalized and specific neurocognitive deficits in prodromal schizophrenia. Biol. Psychiatry59(9), 863–871 (2006).
   PubMed Web of Science ®Google Scholar
• Cannon TD, Cornblatt B, McGorry P. The empirical status of the ultra high-risk (prodromal) research paradigm. Schizophr. Bull.33(3), 661–664 (2007).
   PubMed Web of Science ®Google Scholar
• Pearlson GD, Petty RG, Ross CA, Tien AY. Schizophrenia: a disease of heteromodal association cortex? Neuropsychopharmacology14(1), 1–17 (1996).
   PubMed Web of Science ®Google Scholar
• Keshavan MS, Berger G, Zipursky RB, Wood SJ, Pantelis C. Neurobiology of early psychosis. Br. J. Psychiatry Suppl.48, s8–s18 (2005).
   Google Scholar
• Steen RG, Mull C, McClure R, Hamer RM, Lieberman JA. Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br. J. Psychiatry188, 510–518 (2006).
   PubMed Web of Science ®Google Scholar
• Vita A, De Peri L, Silenzi C, Dieci M. Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies. Schizophr. Res.82(1), 75–88 (2006).
   PubMed Web of Science ®Google Scholar
• Diwadkar VA, Montrose DM, Dworakowski D, Sweeney JA, Keshavan MS. Genetically predisposed offspring with schizotypal features: an ultra high-risk group for schizophrenia? Prog. Neuropsychopharmacol. Biol. Psychiatry30(2), 230–238 (2006).
   PubMed Web of Science ®Google Scholar
• Job DE, Whalley HC, McIntosh AM, Owens DG, Johnstone EC, Lawrie SM. Grey matter changes can improve the prediction of schizophrenia in subjects at high risk. BMC Med.4, 29 (2006).
   PubMed Web of Science ®Google Scholar
• Pantelis C, Velakoulis D, Wood SJ et al. Neuroimaging and emerging psychotic disorders: the Melbourne ultra-high risk studies. Int. Rev. Psychiatry19(4), 371–379 (2007).
   PubMed Web of Science ®Google Scholar
• van Haren NE, Pol HE, Schnack HG et al. Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood. Biol. Psychiatry63(1), 106–113 (2008).
   PubMed Web of Science ®Google Scholar
• McGorry PD, Yung AR, Phillips LJ et al. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch. Gen. Psychiatry59(10), 921–928 (2002).
   PubMed Web of Science ®Google Scholar
• Yung AR, Phillips LJ, Yuen HP, McGorry PD. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr. Res.67(2–3), 131–142 (2004).
   PubMed Web of Science ®Google Scholar
• Garner B, Pariante CM, Wood SJ et al. Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis. Biol. Psychiatry58(5), 417–423 (2005).
   PubMed Web of Science ®Google Scholar
• Glahn DC, Ragland JD, Abramoff A et al. Beyond hypofrontality: a quantitative meta-analysis of functional neuroimaging studies of working memory in schizophrenia. Hum. Brain Mapp.25(1), 60–69 (2005).
   PubMed Web of Science ®Google Scholar
• Fusar-Poli P, Perez J, Broome M et al. Neurofunctional correlates of vulnerability to psychosis: a systematic review and meta-analysis. Neurosci. Biobehav. Rev.31(4), 465–484 (2007).
   PubMed Web of Science ®Google Scholar
• Shergill SS, Brammer MJ, Williams SC, Murray RM, McGuire PK. Mapping auditory hallucinations in schizophrenia using functional magnetic resonance imaging. Arch. Gen. Psychiatry57(11), 1033–1038 (2000).
   PubMed Web of Science ®Google Scholar
• Sanjuan J, Lull JJ, Aguilar EJ et al. Emotional words induce enhanced brain activity in schizophrenic patients with auditory hallucinations. Psychiatry Res.154(1), 21–29 (2007).
   PubMed Web of Science ®Google Scholar
• Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatry160(4), 636–645 (2003).
   PubMed Web of Science ®Google Scholar
• Walters JT, Owen MJ. Endophenotypes in psychiatric genetics. Mol. Psychiatry12(10), 886–890 (2007).
   PubMed Web of Science ®Google Scholar
• Jablensky A. Subtyping schizophrenia: implications for genetic research. Mol. Psychiatry11(9), 815–836 (2006).
   PubMed Web of Science ®Google Scholar
• Gur RE, Calkins ME, Gur RC et al. The Consortium on the Genetics of Schizophrenia: neurocognitive endophenotypes. Schizophr. Bull.33(1), 49–68 (2007).
   PubMed Web of Science ®Google Scholar
• Harris MS, Reilly JL, Keshavan MS, Sweeney JA. Longitudinal studies of antisaccades in antipsychotic-naive first-episode schizophrenia. Psychol. Med.36(4), 485–494 (2006).
   PubMedGoogle Scholar
• Wilson TW, Hernandez OO, Asherin RM, Teale PD, Reite ML, Rojas DC. Cortical gamma generators suggest abnormal auditory circuitry in early-onset psychosis. Cereb. Cortex18(2), 371–378 (2008).
   PubMed Web of Science ®Google Scholar
• Greenwood TA, Braff DL, Light GA et al. Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia. Arch. Gen. Psychiatry64(11), 1242–1250 (2007).
   PubMed Web of Science ®Google Scholar
• Hall MH, Rijsdijk F, Picchioni M et al. Substantial shared genetic influences on schizophrenia and event-related potentials. Am. J. Psychiatry164(5), 804–812 (2007).
   PubMed Web of Science ®Google Scholar
• Laruelle M, Abi-Dargham A. Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies. J. Psychopharmacol.13(4), 358–371 (1999).
   PubMed Web of Science ®Google Scholar
• Erritzoe D, Talbot P, Frankle WG, Abi-Dargham A. Positron emission tomography and single photon emission CT molecular imaging in schizophrenia. Neuroimaging Clin. N. Am.13(4), 817–832 (2003).
   PubMedGoogle Scholar
• Huttunen J, Heinimaa M, Svirskis T et al. Striatal dopamine synthesis in first-degree relatives of patients with schizophrenia. Biol. Psychiatry63(1), 114–117 (2008).
   PubMed Web of Science ®Google Scholar
• Weinberger DR. The biological basis of schizophrenia: new directions. J. Clin. Psychiatry58, 22–27 (1997).
   PubMed Web of Science ®Google Scholar
• Hurlemann R, Matusch A, Kuhn KU et al. 5-HT2A receptor density is decreased in the at-risk mental state. Psychopharmacology (Berl.)195(4), 579–590 (2008).
   PubMed Web of Science ®Google Scholar
• Cornblatt BA, Lencz T, Smith CW et al. Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents. J. Clin. Psychiatry68(4), 546–557 (2007).
   PubMed Web of Science ®Google Scholar
• Jessen F, Scherk H, Traber F et al. Proton magnetic resonance spectroscopy in subjects at risk for schizophrenia. Schizophr. Res.87(1–3), 81–88 (2006).
   PubMedGoogle Scholar
• Stark AK, Uylings HB, Sanz-Arigita E, Pakkenberg B. Glial cell loss in the anterior cingulate cortex, a subregion of the prefrontal cortex, in subjects with schizophrenia. Am. J. Psychiatry161(5), 882–888 (2004).
   PubMed Web of Science ®Google Scholar
• Benes FM, Vincent SL, Todtenkopf M. The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects. Biol. Psychiatry50(6), 395–406 (2001).
   PubMed Web of Science ®Google Scholar
• Rajkowska G, Miguel-Hidalgo JJ, Makkos Z, Meltzer H, Overholser J, Stockmeier C. Layer-specific reductions in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia. Schizophr. Res.57(2–3), 127–138 (2002).
   PubMed Web of Science ®Google Scholar
• Harrison PJ. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain122(Pt 4), 593–624 (1999).
   PubMed Web of Science ®Google Scholar
• Rajkowska G, Selemon LD, Goldman-Rakic PS. Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. Arch. Gen. Psychiatry55(3), 215–224 (1998).
   PubMed Web of Science ®Google Scholar
• Pierri JN, Volk CL, Auh S, Sampson A, Lewis DA. Decreased somal size of deep layer 3 pyramidal neurons in the prefrontal cortex of subjects with schizophrenia. Arch. Gen. Psychiatry58(5), 466–473 (2001).
   PubMedGoogle Scholar
• Hof PR, Haroutunian V, Friedrich VL Jr. et al. Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biol. Psychiatry53(12), 1075–1085 (2003).
   PubMed Web of Science ®Google Scholar
• Benes FM, Davidson J, Bird ED. Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics. Arch. Gen. Psychiatry43(1), 31–35 (1986).
   PubMed Web of Science ®Google Scholar
• Pakkenberg B. Total nerve cell number in neocortex in chronic schizophrenics and controls estimated using optical disectors. Biol. Psychiatry34(11), 768–772 (1993).
   PubMed Web of Science ®Google Scholar
• Selemon LD, Rajkowska G, Goldman-Rakic PS. Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. Arch. Gen. Psychiatry52, 805–818 (1995).
   PubMed Web of Science ®Google Scholar
• Selemon LD, Rajkowska G, Goldman-Rakic PS. Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: application of a three-dimensional, stereologic counting method. J. Comp. Neurol.392(3), 402–412 (1998).
   PubMed Web of Science ®Google Scholar
• Thune JJ, Uylings HB, Pakkenberg B. No deficit in total number of neurons in the prefrontal cortex in schizophrenics. J. Psychiatr. Res.35(1), 15–21 (2001).
   PubMedGoogle Scholar
• Akbarian S, Kim JJ, Potkin SG et al. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch. Gen. Psychiatry52(4), 258–266 (1995).
   PubMed Web of Science ®Google Scholar
• Keshavan MS, Stanley JA, Montrose DM, Minshew NJ, Pettegrew JW. Prefrontal membrane phospholipid metabolism of child and adolescent offspring at risk for schizophrenia or schizoaffective disorder: an in vivo 31P MRS study. Mol. Psychiatry8(3), 316–323, 251 (2003).
   PubMedGoogle Scholar
• Murray RM, Lewis SW. Is schizophrenia a neurodevelopmental disorder? Br. Med. J. (Clin. Res. Ed.)295(6600), 681–682 (1987).
   PubMed Web of Science ®Google Scholar
• Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry44, 660–669 (1987).
   PubMed Web of Science ®Google Scholar
• Keshavan MS, Anderson S, Pettegrew JW. Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited. J. Psychiatr. Res.28(3), 239–265 (1994).
   PubMed Web of Science ®Google Scholar
• Garey LJ, Ong WY, Patel TS et al. Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia [see comments]. J. Neurol. Neurosurg. Psychiatry65(4), 446–453 (1998).
   PubMed Web of Science ®Google Scholar
• Kolluri N, Sun Z, Sampson AR, Lewis DA. Lamina-specific reductions in dendritic spine density in the prefrontal cortex of subjects with schizophrenia. Am. J. Psychiatry162(6), 1200–1202 (2005).
   PubMed Web of Science ®Google Scholar
• Lieberman JA, Perkins D, Belger A et al. The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches. Biol. Psychiatry50(11), 884–897 (2001).
   PubMed Web of Science ®Google Scholar
• Harrison PJ, Owen MJ. Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet361(9355), 417–419 (2003).
   PubMed Web of Science ®Google Scholar
• Dean B, Keriakous D, Scarr E, Thomas EA. Gene expression profiling in Brodmann’s area 46 from subjects with schizophrenia. Aust. NZ J. Psychiatry41(4), 308–320 (2007).
   PubMed Web of Science ®Google Scholar
• Morrison AP, French P, Parker S et al. Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk. Schizophr. Bull.33(3), 682–687 (2007).
   PubMed Web of Science ®Google Scholar
• McGlashan TH, Zipursky RB, Perkins D et al. Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am. J. Psychiatry163(5), 790–799 (2006).
   PubMed Web of Science ®Google Scholar
• Phillips LJ, McGorry PD, Yuen HP et al. Medium term follow-up of a randomized controlled trial of interventions for young people at ultra high risk of psychosis. Schizophr. Res.96(1–3), 25–33 (2007).
   PubMed Web of Science ®Google Scholar
• Thompson PM, Vidal C, Giedd JN et al. Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proc. Natl Acad. Sci. USA98(20), 11650–11655 (2001).
   PubMed Web of Science ®Google Scholar